Open access · US-GOV
via ClinicalTrials.gov Clinical trial
A Study to Evaluate Retisert in the Treatment of Patients With the "Wet" Form of Age-Related Macular Degeneration
Authors not listed
Control Delivery Systems · 2001
Abstract
A study evaluating Retisert in patients with age-related macular degeneration
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-15 MST
Cite this
APA
Anonymous. (2001). A Study to Evaluate Retisert in the Treatment of Patients With the "Wet" Form of Age-Related Macular Degeneration. <em>Control Delivery Systems</em>. https://clinicaltrials.gov/study/NCT00032396
Vancouver
Anonymous. A Study to Evaluate Retisert in the Treatment of Patients With the "Wet" Form of Age-Related Macular Degeneration. Control Delivery Systems. 2001.
BibTeX
@misc{anon2001AStudy,
title = {A Study to Evaluate Retisert in the Treatment of Patients With the "Wet" Form of Age-Related Macular Degeneration},
author = {Anonymous},
journal = {Control Delivery Systems},
year = {2001},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Ophthalmology 2012
Preprint · OA
Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration
Ophthalmology 2006
Citation only
Ranibizumab for Treatment of Neovascular Age-Related Macular Degeneration
Nature reviews. Immunology 2013
Preprint · OA
Immunology of age-related macular degeneration
Advanced Drug Delivery Reviews 2005
Citation only
Wet age-related macular degeneration
American Journal of Ophthalmology 1995
Citation only
A Twin Study of Age-related Macular Degeneration
American Journal of Ophthalmology 2007
Citation only